Whole Bood Serotonin Levels in Cutaneous Mastocytosis, Systemic Mastocytosis and Mast Cell Activation Syndrome

被引：2
|
作者：
Butterfield, J. [1 ]
Weiler, C. [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2011年 / 127卷 / 02期
关键词：
D O I：
10.1016/j.jaci.2010.12.528
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：AB132 / AB132
页数：1
相关论文
共 50 条
  • [1] Higher prevalence of vertebral fractures in systemic mastocytosis, but not in cutaneous mastocytosis and idiopathic mast cell activation syndrome
    Degboe, Y.
    Eischen, M.
    Apoil, P. A.
    Mailhol, C.
    Dubreuil, P.
    Hermine, O.
    Paul, C.
    Livideanu, C. Bulai
    Laroche, M.
    OSTEOPOROSIS INTERNATIONAL, 2019, 30 (06) : 1235 - 1241
  • [2] Higher prevalence of vertebral fractures in systemic mastocytosis, but not in cutaneous mastocytosis and idiopathic mast cell activation syndrome
    Y. Degboé
    M. Eischen
    PA. Apoil
    C. Mailhol
    P. Dubreuil
    O. Hermine
    C. Paul
    C. Bulai Livideanu
    M. Laroche
    Osteoporosis International, 2019, 30 : 1235 - 1241
  • [3] Mastocytosis and clonal mast cell activation syndrome
    Gorska, Aleksandra
    Niedoszytko, Marek
    Lange, Magdalena
    POSTEPY DERMATOLOGII I ALERGOLOGII, 2011, 28 (03): : 217 - 223
  • [4] The Utility of Measuring Urinary Metabolites of Mast Cell Mediators in Systemic Mastocytosis and Mast Cell Activation Syndrome
    Butterfield, Joseph
    Weiler, Catherine R.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2020, 8 (08): : 2533 - 2541
  • [5] CARCINOID-SYNDROME AND DISORDERS OF SYSTEMIC MAST-CELL ACTIVATION INCLUDING SYSTEMIC MASTOCYTOSIS
    ROBERTS, LJ
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 1988, 17 (02) : 415 - 436
  • [6] TRYPTASE LEVELS AS AN INDICATOR OF MAST-CELL ACTIVATION IN SYSTEMIC-ANAPHYLAXIS AND MASTOCYTOSIS
    SCHWARTZ, LB
    METCALFE, DD
    MILLER, JS
    EARL, H
    SULLIVAN, T
    NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (26): : 1622 - 1626
  • [7] Systemic Mastocytosis (SM) and Mast Cell Activation Syndrome (MCAS); How Do They Differ?
    Weiler, Catherine R.
    Alhurani, Rabe E.
    Butterfield, Joseph H.
    Divekar, Rohit
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 141 (02) : AB275 - AB275
  • [8] SYSTEMIC MASTOCYTOSIS AND THE MASTOCYTOSIS SYNDROME
    MONHEIT, GD
    MURAD, T
    CONRAD, M
    JOURNAL OF CUTANEOUS PATHOLOGY, 1979, 6 (01) : 42 - 52
  • [9] Apnea as a manifestation of systemic mast cell activation in an infant with systemic mastocytosis.
    Arnaout, RK
    Irani, A
    Schwartz, LB
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 99 (01) : 2001 - 2001
  • [10] Differences between patients with systemic mastocytosis (SM) and patients with Mast Cell Activation Syndrome (MCAS)
    Weiler, C.
    Alhurani, R. E.
    ALLERGY, 2016, 71 : 299 - 299
12345